Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 6, 2013, Pages

  Jung, Sung Mee ^a,b   Jandu, Simran ^a   Steppan, Jochen ^a   Belkin, Alexey ^c   An, Steven S ^d   Pak, Alina ^a   Choi, Eric Y ^d   Nyhan, Daniel ^a   Butlin, Mark ^e   Viegas, Kayla ^e   Avolio, Alberto ^e   Berkowitz, Dan E ^a   Santhanam, Lakshmi ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yeungnam University College of Medicine   (South Korea)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

Endothelial nitric oxide synthase; Nitric oxide; Pulse wave velocity; S nitrosylation; Tensile testing; Tissue transglutaminase; Vascular stiffness

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEAN ARTERIAL PRESSURE; MOUSE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PULSE WAVE; TENSILE STRENGTH;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PULSE-WAVE VELOCITY; S-NITROSYLATION; TENSILE TESTING; TISSUE TRANSGLUTAMINASE; VASCULAR STIFFNESS;

ANIMALS; AORTA; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GTP-BINDING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; STRESS, MECHANICAL; TENSILE STRENGTH; TRANSGLUTAMINASES; VASCULAR STIFFNESS;

EID: 84884390255     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00103.2013     Document Type: Article

References (29)

1. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148: 825-838, 2000.
2. Alcock J, Warren AY, Goodson YJ, Hill SJ, Khan RN, Lymn JS. Inhibition of tissue transglutaminase 2 attenuates contractility of pregnant human myometrium. Biol Reprod 84: 646-653, 2011.
3. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, Vanbavel E. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 96: 119-126, 2005.
4. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van Rooijen N, Candi E, VanBavel E. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 99: 86-92, 2006.
5. Butlin M, Hammond A, Lindesay G, Viegas K, Avolio AP. In-vitro and in-vivo use of vasoactive agents in characterising aortic stiffness in rats: testing the assumptions. J Hypertension. In press.
6. Chau DY, Collighan RJ, Verderio EA, Addy VL, Griffin M. The cellular response to transglutaminase-cross-linked collagen. Biomaterials 26: 6518-6529, 2005.
7. Davies JE, Rose C, Sarkar S, Rubinsztein DC. Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy. Sci Transl Med 2: 34-40, 2010.
8. Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schillinger RM, An SS, Sham JS, Liggett SB. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 16: 1299-1304, 2010.
9. Elli L, Ciulla MM, Busca G, Roncoroni L, Maioli C, Ferrero S, Bardella MT, Bonura A, Paliotti R, Terrani C, Braidotti P. Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease. Lab Invest 91: 452-461, 2011.
10. Engholm M, Eftekhari A, Chwatko G, Bald E, Mulvany MJ. Effect of cystamine on blood pressure and vascular characteristics in spontaneously hypertensive rats. J Vasc Res 48: 476-484, 2011.
11. Engler AJ, Griffin MA, Sen S, Bonnemann CG, Sweeney HL, Discher DE. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 166: 877-887, 2004.
12. Fabry B, Maksym GN, Butler JP, Glogauer M, Navajas D, Fredberg JJ. Scaling the microrheology of living cells. Phys Rev Lett 87: 148102, 2001.
13. Franklin SS. Hypertension in older people: part 1. J Clin Hypertens (Greenwich) 8: 444-449, 2006.
14. Franklin SS. Hypertension in older people: part 2. J Clin Hypertens (Greenwich) 8: 521-525, 2006.
15. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
16. Iismaa SE, Mearns BM, Lorand L, Graham RM. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89: 991-1023, 2009.
17. Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol 19: 341-352, 2004.
18. Jandu SK, Webb AK, Pak A, Sevinc B, Nyhan D, Belkin AM, Flavahan NA, Berkowitz DE, Santhanam L. Nitric oxide regulates tissue transglutaminase localization and function in the vasculature. Amino Acids 44: 261-269, 2013.
19. Kass DA. Age-related changes in venticular-arterial coupling: pathophysiologic implications. Heart Fail Rev 7: 51-62, 2002.
20. Kobayashi M, Inoue K, Warabi E, Minami T, Kodama T. A simple method of isolating mouse aortic endothelial cells. J Atheroscler Thromb 12: 138-142, 2005.
21. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236-1241, 2001.
22. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121: 505-511, 2010.
23. Ng K, Butlin M, Avolio AP. Persistent effect of early, brief angiotensinconverting enzyme inhibition on segmental pressure dependency of aortic stiffness in spontaneously hypertensive rats. J Hypertens 30: 1782-1790, 2012.
24. Santhanam L, Berkowitz DE, Belkin AM. Nitric oxide regulates nonclassical secretion of tissue transglutaminase. Commun Integr Biol 4: 584-586, 2011.
25. Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, Oh YJ, Sikka G, Kuo M, Halushka MK, Macgregor AM, Dunn J, Gutbrod S, Yin D, Shoukas A, Nyhan D, Flavahan NA, Belkin AM, Berkowitz DE. Decreased S-nitrosylation of tissue transglutaminase contributes to agerelated increases in vascular stiffness. Circ Res 107: 117-125, 2010.
26. Soucy KG, Ryoo S, Benjo A, Lim HK, Gupta G, Sohi JS, Elser J, Aon MA, Nyhan D, Shoukas AA, Berkowitz DE. Impaired shear stressinduced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol 101: 1751-1759, 2006.
27. van den Akker J, VanBavel E, van Geel R, Matlung HL, Guvenc Tuna B, Janssen GM, van Veelen PA, Boelens WC, De Mey JG, Bakker EN. The redox state of transglutaminase 2 controls arterial remodeling. PLos One 6: e23067, 2011.
28. Vanbavel E, Bakker EN. A vascular bone collector: arterial calcification requires tissue-type transglutaminase. Circ Res 102: 507-509, 2008.
29. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25: 932-943, 2005.